These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus: a systematic review of randomised controlled trials and meta-analysis. Teo E; Hassan N; Tam W; Koh S Diabetologia; 2022 Apr; 65(4):604-619. PubMed ID: 35141761 [TBL] [Abstract][Full Text] [Related]
26. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial. Beck RW; Riddlesworth T; Ruedy K; Ahmann A; Bergenstal R; Haller S; Kollman C; Kruger D; McGill JB; Polonsky W; Toschi E; Wolpert H; Price D; JAMA; 2017 Jan; 317(4):371-378. PubMed ID: 28118453 [TBL] [Abstract][Full Text] [Related]
27. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation. Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827 [TBL] [Abstract][Full Text] [Related]
28. Clinical Use of Continuous Glucose Monitoring in Adults with Type 1 Diabetes. Slattery D; Choudhary P Diabetes Technol Ther; 2017 May; 19(S2):S55-S61. PubMed ID: 28541131 [TBL] [Abstract][Full Text] [Related]
29. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi-center, multi-national, randomized controlled trial - Study protocol. Feig DS; Asztalos E; Corcoy R; De Leiva A; Donovan L; Hod M; Jovanovic L; Keely E; Kollman C; McManus R; Murphy K; Ruedy K; Sanchez JJ; Tomlinson G; Murphy HR; BMC Pregnancy Childbirth; 2016 Jul; 16(1):167. PubMed ID: 27430714 [TBL] [Abstract][Full Text] [Related]
30. Continuous Glucose Monitoring and Physical Activity. Schubert-Olesen O; Kröger J; Siegmund T; Thurm U; Halle M Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231598 [TBL] [Abstract][Full Text] [Related]
31. Leveraging advances in diabetes technologies in primary care: a narrative review. Bode B; King A; Russell-Jones D; Billings LK Ann Med; 2021 Dec; 53(1):805-816. PubMed ID: 34184589 [TBL] [Abstract][Full Text] [Related]
32. A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3). Ólafsdóttir AF; Polonsky W; Bolinder J; Hirsch IB; Dahlqvist S; Wedel H; Nyström T; Wijkman M; Schwarcz E; Hellman J; Heise T; Lind M Diabetes Technol Ther; 2018 Apr; 20(4):274-284. PubMed ID: 29608107 [TBL] [Abstract][Full Text] [Related]
33. Assessing the Therapeutic Utility of Professional Continuous Glucose Monitoring in Type 2 Diabetes Across Various Therapies: A Retrospective Evaluation. Kesavadev J; Vigersky R; Shin J; Pillai PBS; Shankar A; Sanal G; Krishnan G; Jothydev S Adv Ther; 2017 Aug; 34(8):1918-1927. PubMed ID: 28667580 [TBL] [Abstract][Full Text] [Related]
34. SELF BLOOD GLUCOSE MONITORING UNDERESTIMATES HYPERGLYCEMIA AND HYPOGLYCEMIA AS COMPARED TO CONTINUOUS GLUCOSE MONITORING IN TYPE 1 AND TYPE 2 DIABETES. Mangrola D; Cox C; Furman AS; Krishnan S; Karakas SE Endocr Pract; 2018 Jan; 24(1):47-52. PubMed ID: 29144814 [TBL] [Abstract][Full Text] [Related]
36. Can the Use of Continuous Glucose Monitoring Improve Glycemic Control in Patients with Type 1 and 2 Diabetes Receiving Dialysis? Bomholt T; Kofod D; Nørgaard K; Rossing P; Feldt-Rasmussen B; Hornum M Nephron; 2023; 147(2):91-96. PubMed ID: 35830847 [TBL] [Abstract][Full Text] [Related]
37. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review. Matsuda E; Brennan P JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140 [TBL] [Abstract][Full Text] [Related]
38. Characterising frailty, metrics of continuous glucose monitoring, and mortality hazards in older adults with type 2 diabetes on insulin therapy (HARE): a prospective, observational cohort study. Fung E; Lui LT; Huang L; Cheng KF; Lau GHW; Chung YT; Ahmadabadi BN; Xie S; Lee JSW; Hui E; So WY; Sung JJY; King I; Goggins WB; Chan Q; Järvelin MR; Ma RCW; Chow E; Kwok T Lancet Healthy Longev; 2021 Nov; 2(11):e724-e735. PubMed ID: 36098029 [TBL] [Abstract][Full Text] [Related]
39. How use of continuous glucose monitoring can address therapeutic inertia in primary care. Martens TW; Parkin CG Postgrad Med; 2022 Aug; 134(6):576-588. PubMed ID: 35584802 [TBL] [Abstract][Full Text] [Related]
40. Exploring the inter-subject variability in the relationship between glucose monitoring metrics and glycated hemoglobin for pediatric patients with type 1 diabetes. Bosoni P; Calcaterra V; Tibollo V; Malovini A; Zuccotti G; Mameli C; Sacchi L; Bellazzi R; Larizza C J Pediatr Endocrinol Metab; 2021 May; 34(5):619-625. PubMed ID: 33823102 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]